Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05318690 · ClinicalTrials.gov registry record · NA

PlayGait: A Dynamic Exoskeleton

A NA study, sponsored by Orthocare Innovations.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT05318690: Clinical Trial NA study, sponsored by Orthocare Innovations.

NCT05318690 is a NA study that was terminated before completion, run by Orthocare Innovations. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05318690, a NA study, was terminated before completion, sponsored by Orthocare Innovations.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.

Primary Outcome

Low, medium, and high activity rate

Interventions

  • OTHER Baseline
  • DEVICE PlayGait

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2022-03-11
Est. Completion 2023-01-03
Phase NA
Orthocare Innovations

4 total trials

Why NCT05318690 stopped before completion

NCT05318690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Baseline is the first listed.

NCT05318690 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05318690 about?

NCT05318690 is a clinical study titled "PlayGait: A Dynamic Exoskeleton". PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assist...

What is the current status of trial NCT05318690?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-03-11. Estimated completion is 2023-01-03.

What interventions are being tested in trial NCT05318690?

The interventions under investigation include: Baseline (OTHER), PlayGait (DEVICE).

Who is sponsoring clinical trial NCT05318690?

This trial is sponsored by Orthocare Innovations, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05318690's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05318690, the US trial registry maintained by the National Library of Medicine. NCT05318690 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.